Table 4.
Groups | GSH-PX (U/mgprot) | T-SOD (U/mgprot) | MDA (nmol/mgprot) |
---|---|---|---|
Normal | 81.57 ± 5.48 | 210.50 ± 2.37 | 0.68 ± 0.10 |
Model | 49.68 ± 6.89** | 131.99 ± 10.19** | 1.57 ± 0.31** |
1% GD | 61.10 ± 6.34 | 138.79 ± 3.78# | 1.24 ± 0.19 |
5% GD | 68.43 ± 7.49# | 184.35 ± 10.02## | 0.97 ± 0.09# |
10% GD | 76.05 ± 5.31## | 197.18 ± 7.74## | 0.79 ± 0.10# |
1% GD, 1% GD-treated diabetic group; 5% GD, 5% GD-treated diabetic group; 10% GD, 10% GD-treated diabetic group. The experimental data are presented as means ± SD. **P < 0.01, respectively, versus normal group; #P < 0.05 and ##P < 0.01, respectively, versus diabetic model group